Bioventus Inc.

8.22
-0.93 (-10.16%)
At close: Apr 04, 2025, 12:39 PM

Company Description

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally.

The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products.

Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement.

The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function.

It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting.

The company was founded in 2011 and is headquartered in Durham, North Carolina.

Bioventus Inc.
Bioventus Inc. logo
Country United States
IPO Date Feb 11, 2021
Industry Medical - Devices
Sector Healthcare
Employees 930
CEO Robert E. Claypoole

Contact Details

Address:
4721 Emperor Boulevard
Durham, North Carolina
United States
Website https://www.bioventus.com

Stock Details

Ticker Symbol BVS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001665988
CUSIP Number 09075A108
ISIN Number US09075A1088
Employer ID 81-0980861
SIC Code 3841

Key Executives

Name Position
Robert E. Claypoole President, Chief Executive Officer & Director
Mark L. Singleton Senior Vice President & Chief Financial Officer
Anthony D'Adamio J.D. Senior Vice President, General Counsel & Corporate Secretary
Dave Venner Senior Vice President & GM of Surgical
David Crawford Vice President of Investor Relations & Treasurer
Helen Leupold Senior Vice President & Chief Human Resources Officer
Katrina J. Church J.D. Senior Vice President & Chief Compliance Officer
Mike Crowe B.S., M.B.A. Senior Vice President of Operations

Latest SEC Filings

Date Type Title
Mar 25, 2025 4 Filing
Mar 21, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 18, 2025 4 Filing
Mar 14, 2025 4 Filing
Mar 14, 2025 4 Filing
Mar 11, 2025 S-8 Filing
Mar 11, 2025 10-K Annual Report
Mar 11, 2025 8-K Current Report
Feb 20, 2025 4 Filing